Homrich & Berg Reduces Position in The Travelers Companies, Inc. (NYSE:TRV)

Palladium Partners Llc who had been investing in Travelers Companies Inc Com for a number of months, seems to be bullish on the $34.76 billion market cap company. (NYSE:TRV) by 4.7% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The company is expected to report EPS as high as $2.54 and as low as $1.56 per share. Hedge funds and other institutional investors own 78.06% of the company's stock. Finally, Balentine LLC increased its position in shares of The Travelers Companies by 2.0% in the first quarter. AQR Capital Management LLC now owns 2,765,369 shares of the insurance provider's stock worth $338,536,000 after buying an additional 101,889 shares in the last quarter. Perigon Wealth Management LLC bought a new stake in shares of The Travelers Companies during the fourth quarter valued at approximately $6,001,000.

The Travelers Companies, Inc. has seen a sales growth quarter over quarter of 3.60%, with sales growth of the past five years coming to 1.70%. Westside Investment Management Inc. now owns 876 shares of the insurance provider's stock valued at $106,000 after buying an additional 686 shares during the period.

Trust Co. of Toledo NA OH raised its position in The Travelers Companies, Inc. HighPoint Advisor Group LLC now owns 2,921 shares of the insurance provider's stock valued at $365,000 after buying an additional 33 shares during the last quarter. Swiss National Bank raised its stake in shares of The Travelers Companies by 25.3% in the first quarter. First Personal Financial Services now owns 889 shares of the insurance provider's stock valued at $107,000 after buying an additional 508 shares during the period. This is an increase from The Travelers Companies's previous quarterly dividend of $0.67. (TRV) opened at 125.43 on Friday.

Capital Wealth Planning Llc decreased The Travelers Companies Inc (TRV) stake by 42.75% reported in 2016Q4 SEC filing. The company has a market capitalization of $35.26 billion, a PE ratio of 12.41 and a beta of 1.21.

The stock last traded at $125.41 which is just over $124.75, the 50 day moving average and marginally over the 200 day moving average of $121.62.

(NYSE:TRV) was down -1.10% during the last trading session, with a day high of 126.98. The company had revenue of $6.18 billion for the quarter, compared to the consensus estimate of $6.25 billion. The Travelers Companies had a net margin of 10.55% and a return on equity of 12.01%. Analysts are expecting EPS growth rates to be at -5.50% this quarter and EPS estimate for next year reflect 6.49% growth rate. Analysts forecast that The Travelers Companies, Inc. will post $9.18 earnings per share for the current year.

Most recently the business also disclosed a divided for the quarter, to be paid on early Fri, Jun 30th. traders with a divided record date on Fri, Jun 9th were paid a $0.72 dividend. This is a positive change from The Travelers Companies's previous quarterly dividend of $0.67. The ex-dividend date was set for Wednesday the 7th of June 2017. The company maintains price to book ratio of 1.49.

ILLEGAL ACTIVITY WARNING: This piece of content was first reported by Stock Observer and is owned by of Stock Observer. The home country is US, and was first put on the stock market on the IPO date, 07/09/1986. If you are viewing this report on another website, it was copied illegally and republished in violation of United States and global copyright law. The legal version of this piece can be viewed at https://www.themarketsdaily.com/2017/07/15/delta-lloyd-nv-has-3-07-million-stake-in-the-travelers-companies-inc-trv-updated-updated-updated.html. Shares outstanding at the moment is 279.84, with the number of shares float at 277.84. The stock of Travelers Companies Inc (NYSE:TRV) has "Buy" rating given on Thursday, December 1 by Citigroup. Finally, Keefe, Bruyette & Woods reissued a "hold" rating and issued a $115.00 target price on shares of The Travelers Companies in a report on Thursday, May 25th. Morgan Stanley reissued an "underweight" rating and set a $119.00 price target (up from $112.00) on shares of The Travelers Companies in a research report on Friday, July 7th. Goldman Sachs maintained the stock with "Neutral" rating in Tuesday, April 26 report. Four analysts have rated the stock with a sell rating, seven have assigned a hold rating and six have given a buy rating to the company's stock. The stock was sold at an average price of $123.48, for a total transaction of $864,360.00. The stock was sold at an average price of $128.72, for a total transaction of $710,276.96. Insider ownership is at a value of 0.40%, while institutions brings a the ownership of institutions to 80.40%. Also, COO Brian W. Maclean sold 87,916 shares of the stock in a transaction that occurred on Monday, April 24th. Shares were disposed in a price range of $120.01, amounting to $10,550,799.16. Following the completion of the transaction, the chief operating officer now directly owns 210,602 shares of the company's stock, valued at $25,274,346.02. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 184,746 shares of company stock valued at $22,540,057.

Argus lifted The Travelers Companies from a "hold" recommendation to a "buy" recommendation and fixed a $132.00 price objective on the shares in a study note on early Mon, Apr 24th. The Firm operates through three divisions: Specialty Products, Chromium and Surfactants.

Notícias recomendadas

We are pleased to provide this opportunity to share information, experiences and observations about what's in the news.
Some of the comments may be reprinted elsewhere in the site or in the newspaper.
Thank you for taking the time to offer your thoughts.